PS Ratio:
N/ASummary
- DNLI price to sales ratio is not available.
Performance
DNLI PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
PS Ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
DNLI PS Ratio Trends
| PeriodPeriod | PS RatioPS Ratio | PricePrice | Market CapMarket Cap | TTM RevenueTTM Revenue |
|---|---|---|---|---|
| 1D1 Day | - | -2.9% | -2.9% | 0.0% |
| 1M1 Month | - | -3.2% | -3.2% | - |
| 3M3 Months | - | +3.3% | +3.7% | 0.0% |
| 6M6 Months | - | -9.3% | -8.7% | - |
| YTDYTD | - | -26.8% | -25.8% | - |
| 1Y1 Year | - | -45.2% | -44.3% | -100.0% |
| 5Y5 Years | - | -71.1% | -64.7% | -100.0% |
DNLI PS Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | ||||
| 3M | 3-Month | ||||
| 6M | 6-Month | ||||
| 1Y | 1-Year | ||||
| 3Y | 3-Year | 3508.51 | 6.57 | ||
| 5Y | 5-Year | 3508.51 | 6.57 | ||
| All-Time | All-Time | 3508.51 | 6.57 |
DNLI PS Ratio History
| Date | Value |
|---|---|
| 2023 | 8.98(-74.2%) |
| 2022 | 34.86(-68.9%) |
| 2021 | 112.08(+272.6%) |
| Date | Value |
|---|---|
| 2020 | 30.08(-52.1%) |
| 2019 | 62.81(+314.9%) |
| 2018 | 15.14 |
FAQ
- What is the all-time high PS ratio for Denali Therapeutics Inc.?
What is the all-time high PS ratio for Denali Therapeutics Inc.?
Denali Therapeutics Inc. all-time high price to sales ratio is 3508.51